CIK 0000885725 · Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042695240
- Phone
- 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +16,863 | $24.55 | $414K | 288,405 |
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +16,863 | $17.26 | $291K | 305,268 |
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +15,642 | $27.09 | $424K | 320,910 |
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise 10b5-1 | +15,086 | $16.31 | $246K | 335,996 |
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Sale 10b5-1 | −64,454 | $75.91 | $4.9M | 271,542 |
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,642 | 46,927 | ||
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,863 | 16,865 | ||
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,086 | 15,087 | ||
| 2024-05-22 | Brennan Daniel J. EVP and CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,863 | 55,600 | ||
| 2024-05-22 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise 10b5-1 | +15,006 | $27.09 | $407K | 47,332 |
| 2024-05-22 | Brown Vance R SVP, GC and Corp. Secretary | Sale 10b5-1 | −15,006 | $76.01 | $1.1M | 32,326 |
| 2024-05-22 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,006 | 0 | ||
| 2024-05-21 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise 10b5-1 | +18,037 | $24.55 | $443K | 50,363 |
| 2024-05-21 | Brown Vance R SVP, GC and Corp. Secretary | Sale 10b5-1 | −18,037 | $75.60 | $1.4M | 32,326 |
| 2024-05-21 | Brown Vance R SVP, GC and Corp. Secretary | Option exercise · Stock Option (Right to Buy) 10b5-1 | −18,037 | 0 | ||
| 2024-05-13 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | Gift | −2,380 | 190,487 | ||
| 2024-05-10 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Option exercise | +12,931 | $16.31 | $211K | 44,352.99 |
| 2024-05-10 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Sale | −12,931 | $74.14 | $959K | 31,421.99 |
| 2024-05-10 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Option exercise · Stock Option (Right to Buy) | −12,931 | 0 | ||
| 2024-05-09 | Zane Ellen M Director | Grant or award | +2,901 | 48,530 |
Page 32 of 40 · 791 trades